Tuesday, November 24, 2015

Dual HER2 Inhibition Flops as Adjuvant Breast Ca Tx (CME/CE)

(MedPage Today) -- Lapatinib-trastuzumab no better than trastuzumab alone

No comments:

Post a Comment